N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.

Abstract excerpt

Recombinant antibodies often contain N-terminal mutations arising from the use of degenerate cloning primer sets and/or the introduction of restriction sites in the framework 1 regions. We studied the effects of such mutations in a recombinant anti-estradiol Fab fragment derived from the hybridoma cell line 57-2. The 5' ends of the heavy and light chain genes were originally modified to introduce the restriction...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibody Affinity
• Share to Antibody Specificity